IDEA Collider: Innovation & Asymmetric Learning in Pharma cover image

The Misconceptions In The Pharma Industry With John L. Lamattina

IDEA Collider: Innovation & Asymmetric Learning in Pharma

00:00

Gene Therapy - The Value of One and Done Therapy

The value of one and done therapy, especially in the U.S., is a commercial challenge for drug companies. What happens if you can cure a disease? What kind of business models that's not science fiction anymore? And how do you price something like this? Well, you can do all sorts of calculations. But what is the value of a life worth? You have that in the UK.

Play episode from 46:34
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app